It was found that 80% of patients who took 'Paxrovid', an oral treatment for COVID-19, improved their symptoms.
The Central Quarantine Countermeasures Headquarters released the treatment progress of 364 patients who received Paxrovid today (21st).
A total of 352 people took the drug for five days among the analyzed subjects.
None of these patients developed severe symptoms or died.
The remaining 12 patients stopped taking the drug because of persistent fever, taste changes, muscle pain, and tachycardia (rapid heart rate).
Of the 301 people who completed taking the drug who responded to the survey, 81.1% said that their symptoms of COVID-19, such as respiratory symptoms and sore throat, improved.
When the symptoms improved, 81.5% said 'within 3 days after starting the drug'.
73.8% of those who finished taking said that they experienced a change in their taste, such as a bitter taste.
However, 75.6% of patients who experienced changes in taste reported that these discomfort symptoms disappeared within 3 days after taking the drug.
89.4% of those who finished taking the drug responded that they would recommend taking the drug to nearby COVID-19 patients.